Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02077465 · COMPLETED
Trial details
- NCT number
- NCT02077465
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-11
- Primary completion
- 2014-10-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.